- Home
- ASM vs BLFS Comparison
ASM vs BLFS Comparison
Compare ASM & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASM | BLFS |
|---|---|---|
| Founded | 1968 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2005 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ASM | BLFS |
|---|---|---|
| Price | $6.02 | $26.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $8.18 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 4.2M | 680.8K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $53.35 | $19.73 |
| Revenue Next Year | $34.26 | $17.82 |
| P/E Ratio | ★ $67.93 | $1,305.00 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $3.10 | $17.86 |
| 52 Week High | $11.99 | $29.57 |
Technical Indicators
Market Signals| Indicator | ASM | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 39.37 | 65.91 |
| Support Level | $5.92 | $26.74 |
| Resistance Level | $6.54 | $28.90 |
| Average True Range (ATR) | 0.38 | 1.29 |
| MACD | -0.12 | 0.13 |
| Stochastic Oscillator | 13.16 | 75.94 |
Price Performance
Historical ComparisonAbout ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.